Liquid biopsy-based single-cell metabolic phenotyping of lung cancer patients for informative diagnostics
Non-invasive methods to predict treatment response are urgently needed. Here in lung cancer, the authors develop a single-cell on-chip cytometry method to metabolically phenotype disseminated tumor cells, revealing metabolic heterogeneity and predictors of therapy response and survival.
Guardado en:
Autores principales: | Ziming Li, Zhuo Wang, Yin Tang, Xiang Lu, Jie Chen, Yu Dong, Baojun Wu, Chunying Wang, Liu Yang, Zhili Guo, Min Xue, Shun Lu, Wei Wei, Qihui Shi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fc6306e74458427db8cad26bd5b3ccb6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer
por: Marta Łukasiewicz, et al.
Publicado: (2021) -
Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors
por: Bardia Yousefi, et al.
Publicado: (2021) -
Liquid Biopsy: A New Translational Diagnostic and Monitoring Tool for Musculoskeletal Tumors
por: Argyris C. Hadjimichael, et al.
Publicado: (2021) -
Diagnostic potential of hypoxia-induced genes in liquid biopsies of breast cancer patients
por: Carlos Henrique F. Peiró, et al.
Publicado: (2021) -
Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma
por: Jiawei Lv, et al.
Publicado: (2019)